Intriguingly, immunophenotypically defined HSCs show robust Cxcl9 and Cxcl10 gene expression, both targets of IFN-γ pathway activation, when neither is secreted by AML blasts. This evidence concerns the gene CXCL10 and acute myeloid leukemia.